
BBWI
USDBath & Body Works Inc.
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$29.710
Kõrge
$29.755
Madal
$29.010
Maht
0.03M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
6.4B
Tööstusharu
Specialty Retail
Riik
United States
Kauplemisstatistika
Keskmine maht
5.79M
Börs
NYQ
Valuuta
USD
52 nädala vahemik
Tehisintellekti analüüsiaruanne
Viimati uuendatud: 25. apr 2025BBWI: Bath & Body Works Inc. - Analyzing Recent Moves & What Might Come Next
Stock Symbol: BBWI Generate Date: 2025-04-25 05:30:22
Let's break down what's been happening with Bath & Body Works stock lately, looking at the news, the price chart, and what some predictions are saying.
Recent News Buzz: Analysts Like the Stock, But See Less Upside
Checking out the latest headlines, you see a few big investment banks weighing in on BBWI. The main takeaway? Analysts generally still have a positive view on the company itself. Firms like Goldman Sachs, Raymond James, JP Morgan, Piper Sandler, and Citigroup all maintain ratings like "Buy," "Outperform," or "Overweight." That's a good sign – it means they think the company is fundamentally sound or has potential.
However, there's a catch. Almost all of them have lowered their price targets. Goldman Sachs went from $49 to $42, Raymond James from $46 to $37, JP Morgan from $47 to $41, Piper Sandler from $38 to $35 (even with an upgrade from Neutral to Overweight), and Citigroup from $48 to $36. What does this tell us? While they still like the stock, they're becoming less optimistic about how high it can go in the near future compared to their previous estimates.
There's also a broader note about consumers looking for discounts and tariff pressures potentially building up. This hints at a tougher environment for retailers like Bath & Body Works, which could be one reason analysts are dialing back their price targets.
So, the news vibe is a bit mixed: positive on the company, but cautious on the stock's immediate price potential due to market conditions.
Price Check: A Recent Dip and Bounce
Looking at the stock's movement over the past month or so, it's been a bit of a rollercoaster. Back in late March, the price was hanging around the $30-$32 mark. Then, in early April, it took a pretty sharp dive, hitting lows near $25. Since that drop, it's bounced back somewhat and has been trading mostly in the $27-$30 range through the middle and latter half of April.
The last recorded price point shows it closing around $29.75 on April 24th. This puts it back above the lowest points from early April but still well below where it was just a month ago, and significantly off its 52-week high of nearly $53.
The AI prediction for today suggests a small upward nudge (0.45%), followed by another tiny gain tomorrow (0.07%), and then a small dip the day after (-0.79%). These are very small predicted moves, suggesting the AI sees things staying relatively flat or slightly volatile in the immediate couple of days.
Putting It Together: What Does This Suggest?
Based on the analyst views, the recent price action, and the AI's short-term forecast, the picture is somewhat complex.
Analysts still rate the stock positively overall, which could appeal to investors looking at the company's longer-term prospects, especially since the stock is trading far below their average target price ($44.67) and its past highs. The company's P/E ratio (around 8.45) is also noted as being moderately below the industry average, which some see as a sign it might be undervalued.
However, the fact that analysts are lowering targets, combined with the stock's recent sharp drop and the AI predicting only minor moves soon, suggests that the immediate path might be challenging or simply range-bound. The retail environment seems tough, and that's likely weighing on things.
One specific recommendation analysis pointed to potential entry points around $28.92 to $29.27, with a stop-loss idea at $26.85 and a take-profit target at $29.3. Interestingly, the current price ($29.75) is now above that suggested take-profit level. This could mean that specific short-term trade idea, if someone followed it, might have already hit its target.
Potential Outlook & Strategy Ideas (Thinking Out Loud):
- For those with a medium-term view: The positive analyst ratings (despite lower targets) and the stock trading well below its highs might make it look interesting. However, the recent price volatility and challenging retail news mean it's not a clear "all-systems-go." It might be a situation for patience or perhaps considering adding shares cautiously on dips, keeping in mind the $26.85 level mentioned as a potential stop-loss if things turn south again.
- For the very short term: The AI predicts minor moves. The specific recommendation's take-profit level has already been passed. This suggests the immediate bounce might have run its course for now, or that the stock could trade sideways around current levels. Risk management is key if trading short-term swings.
Overall, the situation seems to lean towards a "Hold" for those already in, or perhaps "Cautious Accumulation" on weakness for those interested long-term, given the analyst sentiment versus the recent price action and market headwinds. It doesn't scream "buy aggressively right now," but it also doesn't look like analysts are abandoning the ship entirely.
Company Context
Remember, Bath & Body Works is a big specialty retailer focusing on things like candles, soaps, and body care. They operate stores and sell online. Being in the "Consumer Cyclical" sector means their business can be quite sensitive to how the overall economy is doing and how much discretionary money people have to spend on non-essentials. The news about consumers going discount fits right into this context – when money is tight, people might cut back on these kinds of purchases.
Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.
Seotud uudised
Loeb's Third Point builds stake in Band-Aid maker Kenvue
Billionaire investor Daniel Loeb's hedge fund Third Point is building a stake in Kenvue , sources familiar with the matter said on Friday, as some investors are pushing for strategic changes at the consumer healthcare company.
Goldman Sachs Maintains Buy on Bath & Body Works, Lowers Price Target to $42
Goldman Sachs analyst Kate McShane maintains Bath & Body Works with a Buy and lowers the price target from $49 to $42.
Raymond James Maintains Outperform on Bath & Body Works, Lowers Price Target to $37
Raymond James analyst Olivia Tong maintains Bath & Body Works with a Outperform and lowers the price target from $46 to $37.
Consumers Go Discount As Tariff Pressures Mount, Warns Analyst
Retail sector momentum is building as some global brands show improving visibility, while diversified specialty retailers benefit from operational gains and product mix strength.
JP Morgan Maintains Overweight on Bath & Body Works, Lowers Price Target to $41
JP Morgan analyst Matthew Boss maintains Bath & Body Works with a Overweight and lowers the price target from $47 to $41.
Piper Sandler Upgrades Bath & Body Works to Overweight, Lowers Price Target to $35
Piper Sandler analyst Korinne Wolfmeyer upgrades Bath & Body Works from Neutral to Overweight and lowers the price target from $38 to $35.
Citigroup Maintains Buy on Bath & Body Works, Lowers Price Target to $36
Citigroup analyst Paul Lejuez maintains Bath & Body Works with a Buy and lowers the price target from $48 to $36.
Tehisintellekti ennustusBeta
Tehisintellekti soovitus
Uuendatud kell: 28. apr 2025, 06:40
65.7% Kindlus
Risk ja kauplemine
Sisenemispunkt
$29.41
Võta kasum
$31.73
Peata kahjum
$26.63
Põhitegurid
Seotud aktsiad

BATRA
Atlanta Braves Holdings Inc. Series A

ZIM
ZIM Integrated Shipping Services Ltd. Ordinary Shares

GOOGL
Alphabet Inc.

ELA
Envela Corporation

BIPI
BIP Bermuda Holdings I Limited 5.125% Perpetual Subordinated Notes
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.